Home › Neuroblastoma › New York › New York City
Neuroblastoma clinical trials in New York City, NY
10 studies for Neuroblastoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
RecruitingPhase 2Healthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Memorial Sloan Kettering Kids, New York
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- Hartford, CT8 studies
- Aurora, CO8 studies
- Minneapolis, MN8 studies
- Orlando, FL7 studies
- Miami, FL7 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.